255885-47-3

Basic information

• Product Name: Piperazine, 1-[[3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin- 5-yl)-4-ethoxyphenyl]sulfonyl]-4-methyl-, monoacetate
• CAS NO: 255885-47-3
• Molecular Formula: C22H30N6O4S.C2H4O2
• Molecular Weight: 534.637
• Mol File: 255885-47-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Piperazine, 1-[[3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin- 5-yl)-4-ethoxyphenyl]sulfonyl]-4-methyl-, monoacetate(CAS DataBase Reference)
• NIST Chemistry Reference: Piperazine, 1-[[3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin- 5-yl)-4-ethoxyphenyl]sulfonyl]-4-methyl-, monoacetate(255885-47-3)
• EPA Substance Registry System: Piperazine, 1-[[3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin- 5-yl)-4-ethoxyphenyl]sulfonyl]-4-methyl-, monoacetate(255885-47-3)

Safety Data

• Hazardous Substances Data: 255885-47-3(Hazardous Substances Data)

Upstream product

• 64-19-7 acetic acid 
• 139755-83-2 sildenafil 

Relevant articles and documents

FORMULATIONS OF PHOSPHODIESTERASE 5 INHIBITORS AND METHODS OF USE

The present invention provides compositions and delivery methods to enhance treatment for sexual dysfunction or hypofunction through the delivery of phosphodiesterase 5 inhibitors to a mammal. Phosphodiesterase inhibitors are one example of a compound class used for this indication. Examples of compounds in this class include taldalafil and vardenafil and sildenafil. Furthermore, the present invention provides compositions and delivery methods to enhance the sildenafil concentration in solution, suspension and gel formulations and methods of parenteral, intradermal, sublingual, intranasal, and buccal sildenafil delivery.